Microtiter plate assays
IVD tests for SphingoTec’s proprietary biomarkers are made available as sphingotest® microtiterplate tests. Get in touch to order our products or request more information
…
With the mission of improving patient management in critical care settings, SphingoTec has started a series of collaboration with internationally leading academic and non-academic medical centers.
Our skilled international team has a breadth of experience in life sciences, disease biology, biotechnology, and clinical in vitro diagnostics and is dedicated to supporting the medical community and…
Next to our Nexus IB10 automated and portable immunoassay system we also provide customized MTP assays and testing services to fulfill the specific requirements of our customers.
SphingoTec has an international qualified network of distribution partners with which we work in close cooperation and mutual support. We are committed to providing our partners with exceptional…
Diagnostics company SphingoTec GmbH announced the implementation of two critical care biomarkers to guide the application of a potential new drug candidate for the treatment of COVID-19 patients.
In severely ill COVID-19 patients, besides the main complications that include respiratory, cardiovascular and kidney diseases, an emerging body of evidence shows that endothelial function plays a…
For higher throughput, IVD tests for SphingoTec’s proprietary biomarkers for critical care and preventive medicine are made available as sphingotest® microtiterplate assays.
SphingoTec is a fully integrated diagnostic solutions provider based in Hennigsdorf near Berlin and San Diego, CA. SphingoTec’s first-in-class biomarker tests are made available on its proprietary…
The CE-IVD marked Nexus IB10 platform is a fully automated rapid immunoassay point-of-care instrument. With a hands-on-time of less than 3 minutes the easy-to-use system provides in only 20 minutes…
